(Q59567864)
Statements
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection (English)
Shashank S Ghantoji
Dhara N Shah
Musarat Habib
Vaneet Arora
Zhi-Dong Jiang
Herbert L DuPont
21 September 2011